DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Lozanski G. et al.
Alemtuzumab is an effective therapy for chronic lymphocytic
leukemia with p53 mutations and deletions.
Blood 2004; 103 (9) 3278-81
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.